About Me
Melanoma
Pigmented skin lesions
Skin cancer
Supportive oncodermatology
General dermatology
Services and treatments
Credentials
Board Certifications
Dermatology
Medical School
University of Missouri, 2015
Internship
Mercy Hospital St. Louis, 2016
Residency
Dermatology, University of Missouri, 2019
Fellowship
Complex Medical Dermatology, Brigham & Women's Hospital, 2020
Publications
Apalla Z, Freites-Martinez A, Grafanaki K, et al including Hirner J. Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process. J Eur Acad Dermatol Venereol. 2024. E-pub ahead of print. doi: 10.1111/jdv.20391.
Bang AS, Said JT, Hirner J, et al. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer. Support Care Cancer. 2024;32(6):354. doi: 10.1007/s00520-024-08551-x.
Adebiyi A, Praveen R, Hirner J, et al. Comparison of three deep learning models in accurate classification of 770 dermoscopic skin lesion images. J Am Med Inform Assoc. 2024;31;2024:46-53.
Larocca CA, Fay CJ, Hirner JP, et al. Diffuse cutaneous aphthosis due to combined targeted cancer therapies and responsive to pentoxifylline: a novel dermatologic adverse event presenting as a morphologic mimic of Degos Disease and Behcet’s Disease. JAMA Dermatol. 2023;159(10):1136-1139. doi:10.1001/jamadermatol.2023.2649
Mital R, Otto TS, Savu A, et al including Hirner J. Detection of novel therapies using a multinational, multi-institutional registry of cutaneous immune-related adverse events and management. Int J Dermatol. 2023;202;62(8):1020-1025. doi: 10.1111/ijd.16714
Hirner J. Updates in cutaneous oncology. Mo Med. 2023;120(1):53-58. PMID: 36860605
Becker NV, Bakshi S, Martin KL, et al including Hirner JP. Provider experience and satisfaction with a novel virtual team rounding program during the COVID-19 pandemic. Int J Qual Health Care. 2021;33(3):1-7. doi:10.1093/intqhc/mzab111
Becker NV, Bakshi S, Martin KL, et al including Hirner JP. Virtual team rounding: A cross-specialty inpatient care staffing program during the COVID-19 pandemic. Acad Med. 2021; 96(12):1717-21. doi: 10.1097/ACM.0000000000004208
Bui AN, Singer S, Hirner J, et al. Cutaneous connective tissue disease associated with immune checkpoint inhibitor therapy: a retrospective analysis. J Am Acad Dermatol. 2021;84(3):864-9. doi: 10.1016/j.jaad.2020.10.054
Bui AN, Hirner J, Singer S et al. De novo subacute cutaneous lupus erythematosus like eruption in the setting of PD-1 or PD-L1 inhibitor therapy: clinicopathologic correlation. Clin Exp Dermatol. 2021;46(2):328-37. doi: 10.1111/ced.14449
Hirner J, Cleary JM, Sheets A, Murphy G, LeBoeuf N. Fibroblast growth factor receptor inhibitors and nonuremic calciphylaxis. JAMA Dermatol. 2021;157(1):119-21. doi: 10.1001/jamadermatol.2020.4076
Hirner JP, O’Malley JT, LeBoeuf N. Blastic plasmacytoid dendritic cell neoplasm: the dermatologist’s perspective. Hematol Oncol Clin North America. 2020;(34)3:501-9. doi: 10.1016/j.hoc.2020.01.001
Hirner, J. Subacute cutaneous lupus erythematosus with a possible paraneoplastic association with melanoma. BMJ Case Rep. 2019;12(11):e230558. doi: 10.1136/bcr-2019-230558
Hirner J, Day M. Does use of compression stockings after DVT improve outcomes? Evidence-Based Practice. 2016;19(3):12-14. doi: 10.1097/01.EBP.0000541176.09862.1a
Hirner JP, Koopman PJ. Lupus pernio as the presenting symptom of sarcoidosis: a case report.
Missouri Family Physician. 2014;33(4):8-10.
Choma TJ, Pfeiffer FM, Swope RW, Hirner JP. Pedicle screw design and cement augmentation in osteoporotic vertebrae: effects of fenestrations and cement viscosity on fixation and extraction. Spine. 2012;37(26):1628-32. doi: 10.1097/BRS.0b013e3182740e56